002900 Harbin Medisan Pharmaceutical
- 9.26
- +0.09+0.98%
Harbin Medisan Pharmaceutical News
Kazakh Triptych: An indicative announcement on the 2022 Restricted Stock Incentive Plan to lift the listing and circulation of restricted shares during the second lifting period
Kazakh Sanlian: Announcement on progress in providing guarantees for wholly-owned subsidiaries
Kazakh Sanlian: Announcement on changing the registered capital and amending the “Articles of Association”
Kazakh Sanlian: Legal Opinion of Beijing Zhonglun Law Firm on the 2022 Restricted Stock Incentive Plan of Harbin Sanlian Pharmaceutical Co., Ltd. on the achievements of lifting sales restrictions during the second period of lifting restrictions, adjustment of repurchase prices, and matters relating to the repurchase and cancellation of some restricted stocks
Kazakh Sanlian: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on matters relating to the achievements of the 2022 Restricted Stock Incentive Plan of Harbin Sanlian Pharmaceutical Co., Ltd., the results of lifting sales restrictions and the repurchase and cancellation of some restricted stocks
Kazakh Sanlian: Announcement on Adjusting the Repurchase Price of the 2022 Restricted Stock Incentive Plan
Kazakh Sanlian: Announcement on Closing Some Fundraising Projects and Using Savings Raised to Permanently Replenish Liquidity
Kazakh Triptych: Announcement on the achievements of the 2022 Restricted Stock Incentive Plan to lift the sales restrictions during the second period of lifting the sales restriction period
Kazakh Triptych: Announcement of Resolutions of the 14th Meeting of the Fourth Board of Supervisors
Kazakh Sanlian: SDIC Securities\'s inspection opinion on the completion of the fund-raising project of Harbin Sanlian Pharmaceutical Co., Ltd. and raising funds with savings to supplement working capital
Kazakh Sanlian: Announcement on not holding a shareholders\' meeting for the time being
Kazakh Triptych: Supervisory Board\'s Review Opinions on the 2022 Restricted Stock Incentive Plan\'s Second Lifted Period to Lift the Sales Restriction Incentive List
Kazakh Triptych: Announcement on Using Idle Own Funds for Entrusted Financial Management
Kazakh Triptych: Announcement of Resolutions of the Third Special Meeting of Independent Directors of the Fourth Board of Directors in 2024
Kazakh Triptych: Announcement of Resolutions of the 17th Meeting of the Fourth Board of Directors
Kazakh Sanlian: Announcement on the Repurchase and Cancellation of Some Restricted Shares in the 2022 Restricted Stock Incentive Plan
Kazakh Sanlian: Summary table of non-operating capital usage and other related capital transactions for the first half year
Kazakh Triptych: 2024 semi-annual financial report
Kazakh Triptych: Special Report on the Deposit and Use of Funds Raised for the Semiannual Year of 2024
Kazakh Triptych: 2024 Semi-Annual Report
Analysis
Price Target
No Data
No Data